Fundraising Fox

Karen LaRochelle

Investor

Venture Partner at Advent Life Sciences

Princeton, New Jersey

Writes $25K – $5M checks Β· typically $1M

About

Karen LaRochelle is Senior Vice President of Global Business Development and Strategy at Merz Therapeutics. She serves as a board director and brings over 30 years of experience in biotechnology and pharmaceutical transactions and strategy.

Experience

  1. Merz TherapeuticsSVP, Global Business Development and Strategycurrent2025 β€” present
  2. PaxMedicaBoard Member2020 β€” 2025
  3. LaRochelle AdvisorsConsulting Chief Business Officer to multiple biotechs2013 β€” 2025
  4. Advent Life Sciences LLPOperational Partner2020 β€” 2023
  5. WindMIL TherapeuticsSVP, Corporate and Business Development2020 β€” 2021
  6. Psioxus TherapeuticsChief Business Officer2016 β€” 2019Oxford, United Kingdom and Philadelphia, PA
  7. Bristol-Myers SquibbGlobal Business Development & Head of China Business Development1993 β€” 2013
  8. Anderson ConsultingConsultant1988 β€” 1991

Education

  1. Columbia Business SchoolMaster of Business Administration (M.B.A.), Finance1991 β€” 1993
  2. Lehigh UniversityBachelor of Applied Science (BASc), Industrial Engineer1984 β€” 1988

Skills & more

Negotiation17Contract Negotiation5Licensing24China Business Development2Pharmaceutical Industry52Valuation Modeling3Global Alliance Management3Strategic Planning8Business Development27Acquisitions4Strategy28Strategic Alliances6
+12 moreDiabetesLeadershipCompetitive AnalysisOncologyBiotechnologyGlobal Business DevelopmentMergers & AcquisitionsTechnology TransferBiopharmaceuticalsCommercializationDrug DevelopmentClinical Development

From Karen's professional profile.

Same school

Shared employers

Colleagues at Advent Life Sciences

Network4

Investors connected to Karen in public investor directories β€” a warm-intro map.